{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:32Z","timestamp":1786114892663,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202340187"],"award-info":[{"award-number":["202340187"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571029"],"award-info":[{"award-number":["82571029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eprac.2026.01.022","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:49:03Z","timestamp":1769759343000},"page":"737-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Superior Efficacy of Denosumab Over Zoledronic Acid in Increasing Femoral Neck Bone Mineral Density in Osteoporosis Patients With Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"32","author":[{"given":"Dongxu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-6987","authenticated-orcid":false,"given":"Lige","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2026.01.022_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101779","article-title":"Diabetes and osteoporosis - treating two entities: a challenge or cause for concern?","volume":"36","author":"Rasmussen","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.eprac.2026.01.022_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.531904","article-title":"Correlation of osteoporosis in patients with newly diagnosed type 2 diabetes: a retrospective study in Chinese population","volume":"12","author":"Wen","year":"2021","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.022_bib3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jdiacomp.2015.05.007","article-title":"Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care","volume":"29","author":"Rathmann","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.eprac.2026.01.022_bib4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","article-title":"Iowa women\u2019s health study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women","volume":"24","author":"Nicodemus","year":"2001","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2026.01.022_bib5","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s00198-015-3162-6","article-title":"A survey of outcomes and management of patients post fragility fractures in China","volume":"26","author":"Wang","year":"2015","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.eprac.2026.01.022_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/cen.14501","article-title":"Characteristics of bone metabolism in postmenopausal women with newly diagnosed type 2 diabetes mellitus","volume":"95","author":"Li","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.022_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/JBMR.051018","article-title":"Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial","volume":"21","author":"Bauer","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.022_bib8","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1210\/jc.2004-1091","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib9","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EJE-18-0056","article-title":"Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis","volume":"179","author":"Anastasilakis","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.01.022_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116289","article-title":"Bisphosphonates: the role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use","volume":"156","author":"Ebetino","year":"2022","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.022_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.eprac.2026.01.022_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.01.022_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal Osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.01.022_bib14","first-page":"S15","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eprac.2026.01.022_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.eprac.2026.01.022_bib16","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jbmr.3538","article-title":"Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry","volume":"33","author":"Leslie","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11657-024-01475-3","article-title":"Effects of Denosumab and Zoledronic acid on postmenopausal osteoporosis, bone density, and fat-free mass","volume":"20","author":"Ha","year":"2025","journal-title":"Arch Osteoporos"},{"issue":"13","key":"10.1016\/j.eprac.2026.01.022_bib18","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.3346\/jkms.2022.37.e68","article-title":"Comparison of Denosumab and Zoledronic acid in postmenopausal women with osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)","volume":"37","author":"Kang","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"11","key":"10.1016\/j.eprac.2026.01.022_bib19","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jbmr.4697","article-title":"Diabetes Mellitus and the benefit of antiresorptive therapy on fracture risk","volume":"37","author":"Eastell","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12020-023-03432-5","article-title":"Effect of a single dose of Zoledronic acid on bone mineral density and trabecular bone score in Indian postmenopausal osteoporotic women with and without type 2 diabetes mellitus - a prospective cohort pilot study","volume":"82","author":"Merugu","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2026.01.022_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115268","article-title":"Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension","volume":"134","author":"Ferrari","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.eprac.2026.01.022_bib22","article-title":"The efficacy of Alendronate versus Denosumab on major osteoporotic fracture risk in elderly patients with diabetes mellitus: a Danish Retrospective Cohort Study","volume":"12","author":"Viggers","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2026.01.022_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1590472","article-title":"Zoledronic acid and Denosumab are associated with similar fracture incidence and mortality in patients with type 2 diabetes: a population-based cohort study","volume":"16","author":"Rouach","year":"2025","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","article-title":"Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect","volume":"12","author":"El-Masri","year":"2024","journal-title":"Bone Res"},{"issue":"Supplement_3","key":"10.1016\/j.eprac.2026.01.022_bib25","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.eprac.2026.01.022_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jbmr.3631","article-title":"Reduction of cortical bone turnover and erosion depth after 2 and 3 years of denosumab: iliac bone histomorphometry in the FREEDOM trial","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.022_bib27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1359\/jbmr.070906","article-title":"Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure","volume":"23","author":"Recker","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.eprac.2026.01.022_bib29","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jbmr.81","article-title":"Microarchitectural deterioration of cortical and trabecular bone: differing effects of Denosumab and Alendronate","volume":"25","author":"Seeman","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.022_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.eprac.2026.01.022_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.00-0463","article-title":"Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear Factor-kappaB","volume":"15","author":"Langen","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.eprac.2026.01.022_bib32","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eprac.2026.01.022_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/DHPS.S7727","article-title":"Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis","volume":"3","author":"Lewiecki","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12891-024-07323-2","article-title":"Association of Sarcopenia with osteoporosis in Chinese patients with type 2 diabetes","volume":"25","author":"Xu","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12902-018-0290-y","article-title":"Effect of duration of diabetes on bone mineral density: a population study on East Asian males","volume":"18","author":"Jang","year":"2018","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.022_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11657-025-01580-x","article-title":"The relationship between type 2 diabetes mellitus, prediabetes, and bone mineral density in middle-aged and older adults: a nationwide study","volume":"20","author":"Liao","year":"2025","journal-title":"Arch Osteoporos"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2600039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2600039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:48:04Z","timestamp":1785970084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2600039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1530891X2600039X"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.01.022","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superior Efficacy of Denosumab Over Zoledronic Acid in Increasing Femoral Neck Bone Mineral Density in Osteoporosis Patients With Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}